<?xml version="1.0" ?>
<document id="6dc7f0acaa45433001b3b0586094e88c0d400911">
  <chunk id="6dc7f0acaa45433001b3b0586094e88c0d400911.c0" text="Quantitative analysis of rutin, quercetin, naringenin, and gallic acid by validated RP-and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera senegalensis">
    <entity charOffset="59-70" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c0.e0" ontology_id="CHEBI_30778" text="gallic acid" type="chemical"/>
    <entity charOffset="66-70" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c0.e1" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
  </chunk>
  <chunk id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1" text="Context: Guiera senegalensis J.F. Gmel (Combretaceae) is a folk medicinal plant used in various metabolic and infectious diseases. In addition to its antiviral activities against herpes and fowlpox, the anti-HBV efficacy is very recently reported. Objective: To develop and validate simple, sensitive RP-/NP-HPTLC methods for quantitative determination of biomarkers rutin, quercetin, naringenin, and gallic acid in the anti-HBV active G. senegalensis leaves ethanol-extract. Materials and methods: RP-HPTLC (rutin &amp; quercetin; phase-acetonitrile:water, 4:6) and NP-HPTLC (naringenin &amp; gallic acid; phase-toluene:ethyl acetate:formic acid, 6:4:0.8) were performed on glass-backed silica gel plates 60F 254 -RP18 and 60F 254 , respectively. The methods were validated according to the ICH guidelines.">
    <entity charOffset="150-159" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e0" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="367-372" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e1" ontology_id="CHEBI_28527" text="rutin" type="chemical"/>
    <entity charOffset="385-395" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e2" ontology_id="CHEBI_17846" text="naringenin" type="chemical"/>
    <entity charOffset="401-412" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e3" ontology_id="CHEBI_30778" text="gallic acid" type="chemical"/>
    <entity charOffset="408-412" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e4" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="509-514" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e5" ontology_id="CHEBI_28527" text="rutin" type="chemical"/>
    <entity charOffset="573-583" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e6" ontology_id="CHEBI_17846" text="naringenin" type="chemical"/>
    <entity charOffset="586-597" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e7" ontology_id="CHEBI_30778" text="gallic acid" type="chemical"/>
    <entity charOffset="593-597" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e8" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="634-638" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e9" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="680-686" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c1.e10" ontology_id="CHEBI_30563" text="silica" type="chemical"/>
  </chunk>
  <chunk id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2" text="Results: Well-separated and compact spots (R f ) of rutin (0.52 ± 0.006), quercetin (0.23 ± 0.005), naringenin (0.56 ± 0.009) and gallic acid (0.28 ± 0.006) were detected. The regression equations (Y) were 12.434x þ 443.49, 10.08x þ 216.85, 11.253x þ 973.52 and 11.082x þ 446.41 whereas the coefficient correlations (r 2 ) were 0.997 ± 0.0004, 0.9982 ± 0.0001, 0.9974 ± 0.0004 and 0.9981 ± 0.0001, respectively. The linearity ranges (ng/spot) were 200-1400 (RP-HPTLC) and 100-1200 (NP-HPTLC). The LOD/LOQ (ng/band) were 33.03/100.1 (rutin), 9.67/29.31 (quercetin), 35.574/107.8 (naringenin), and 12.32/37.35 (gallic acid). Gallic acid (7.01 lg/mg) was the most abundant biomarker compared to rutin (2.42 lg/mg), quercetin (1.53 lg/ mg) and naringenin (0.14 lg/mg) in the extract. Conclusion: The validated NP-/RP-HPTLC methods were simple, accurate, and sensitive for separating and quantifying antiviral biomarkers in G. senegalensis, and endorsed its anti-HBV activity. The developed methods could be further employed in the standardization and quality-control of herbal formulations.">
    <entity charOffset="52-57" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e0" ontology_id="CHEBI_28527" text="rutin" type="chemical"/>
    <entity charOffset="74-83" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e1" ontology_id="CHEBI_16243" text="quercetin" type="chemical"/>
    <entity charOffset="100-110" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e2" ontology_id="CHEBI_17846" text="naringenin" type="chemical"/>
    <entity charOffset="130-141" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e3" ontology_id="CHEBI_30778" text="gallic acid" type="chemical"/>
    <entity charOffset="137-141" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e4" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="623-634" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e5" ontology_id="CHEBI_30778" text="Gallic acid" type="chemical"/>
    <entity charOffset="630-634" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e6" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="670-679" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e7" ontology_id="CHEBI_59163" text="biomarker" type="chemical"/>
    <entity charOffset="692-697" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e8" ontology_id="CHEBI_28527" text="rutin" type="chemical"/>
    <entity charOffset="712-721" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e9" ontology_id="CHEBI_16243" text="quercetin" type="chemical"/>
    <entity charOffset="740-750" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e10" ontology_id="CHEBI_17846" text="naringenin" type="chemical"/>
    <entity charOffset="895-904" id="6dc7f0acaa45433001b3b0586094e88c0d400911.c2.e11" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
  </chunk>
  <chunk id="6dc7f0acaa45433001b3b0586094e88c0d400911.c3" text="ARTICLE HISTORY"/>
</document>
